Actionable news
All posts from Actionable news
Actionable news in OMER: Omeros Corporation,

Omeros: Major Upside Ahead For This Small Biotech


Omeros Corporation is an intriguing small concern with one approved product and an evolving pipeline.

The stock is way under analyst price targets and has upcoming catalysts as well.

Why the stock seems significantly undervalued is profiled below in a very granular deep-dive analysis.

Fourth of July Weekend Promotion: Free two week trials are now being offered on the Biotech Forum investment service through midnight EST, July 5th.

This weekend's deep-dive biotech profile is around an attractive investment opportunity in a small biotech company with one approved product and multiple "shots on...